What is Offlimits?
Offlimits distinguishes itself in the competitive cereal market by offering unique flavor profiles and functional ingredients. Their product line includes 'Dash,' which incorporates Intelligentsia coffee and cacao to create a cold brew effect in milk, and 'Zombie,' formulated with adaptogens like pandan, vanilla, and ashwagandha for a calming effect. Both cereal varieties are crafted from organic, vegan, gluten-free, and lightly sweetened whole ingredients, catering to health-conscious consumers. Headquartered in New York, New York, Offlimits is positioning itself as a modern, ingredient-forward brand.
How much funding has Offlimits raised?
Offlimits has raised a total of $2.3M across 1 funding round:
Unspecified
$2.3M
Unspecified (2021): $2.3M with participation from Moksha Fitzgibbons, Dana Cowin, Science Inc., Nick Tran, Canaan Partners, Crosslink, and Marc Lotenberg
Key Investors in Offlimits
Canaan Partners
Canaan Partners is a venture capital firm focused on early-stage technology and healthcare companies, providing backing from seed to growth stages across various sectors including enterprise software, fintech, consumer, biopharma, and digital health.
Crosslink
Crosslink is a company with expertise in Electrochemistry and Polymer Science, focused on commercializing advanced solutions and bringing step-change advancements to customer products through scientific and business development.
What's next for Offlimits?
The recent major strategic investment signals a pivotal phase for Offlimits, likely enabling the company to scale production, expand its distribution channels, and further develop its product innovation pipeline. This capital infusion is expected to bolster its market presence and support its mission to redefine breakfast options with functional and high-quality ingredients. The company's focus on unique formulations and health benefits positions it for continued expansion within the evolving consumer packaged goods landscape.
See full Offlimits company page
